Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Drugrecure ApS, a subsidiary of Savara, Inc., is a Danish company that provides health care services.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Part of ReproCELL, Inc., Genomics Collaborative, Inc. is an American company located in Cambridge, MA, that provides clinical samples and the application of human genetics to target validation for drug discovery. The firm was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative, Inc. was acquired by BioServe Biotechnologies Ltd., a subsidiary of ReproCELL, Inc. since May 2019, from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Zaporizhzhia State Medical University (ZSMU) is a medical university in the small city of Zaporizhzhia, Ukraine.

SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.

Versitech Ltd. is a company headquartered in Hong Kong, Hong Kong and ultimately controlled by the Government of Hong Kong Special Administrative Region. The firm provides business services.

Zhengzhou Lydia Pharmaceutical Technology Co., Ltd., established on 2015-11-20, Business scope includes medical technology development,technology transfer,Technical Consulting and Technical Services;Chemical technology development,technology transfer,Technical Consulting and Technical Services;Sales:Chemical Products(flammable,Explosive,Precursor,Excluding hazardous chemicals),Instrumentation,ink,building materials;data processing services;Development of computer software and hardware technology,technical consulting,Transfers and Services;software development;Computer System Integration Services.

The Academic Medical Center (Dutch: Academisch Medisch Centrum), or AMC, is the university hospital affiliated with the Universiteit van Amsterdam (University of Amsterdam). It is one of the largest and leading hospitals of The Netherlands, located in the Bijlmer neighborhood in the most south-eastern part of the city. AMC consistently ranks among the top 50 medical schools in the world.

Guangdong Juzhicheng Technology Co., Ltd., established on 2014-11-14, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;data processing services;software development;Artificial intelligence application software development;Information system integration service;New material technology promotion service;Intellectual Property Services(Trademark agency service,Except for patent agency services);Business Management Consulting;Technology intermediary service;Information Consulting Service(Not including licensing information consulting services);Consulting and planning service;Biochemical product technology research and development;Biomass Energy Technology Services;Digital Content Production Services(Does not include publishing);Sales of digital cultural and creative technology and equipment;Digital cultural and creative content application services;Digital culture creative software development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Qingdao Huazhicao Pharmaceutical Technology Co., Ltd., established on 2015-09-06, Business scope includes medical technology development,technical consulting,Technology Promotion,Technical Services;Operating other general business items that can be operated without administrative approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Baochuang Biotechnology Co., Ltd., established on 2009-12-08, Business scope includes non-licensed medical device business;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Medical Research and Experimental Development;Medical equipment rental service;Biotechnology Development Services;Biotechnology Extension Services;Biomedical Technology Research;Import and export(Excluding franchised products);Technology Import and Export;Research and development of biological products(Does not include licensed operations);Research and development of biodiagnostic reagents and kits(Does not include license approval items);Biotechnology Consulting,communication service;Medical technology research and development;Sales of biological diagnostic reagents and kits(Does not include license approval items);Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Sales of Biological Products(Does not include licensed operations);Biotechnology Transfer Services;trade agent;medical diagnosis,Monitoring and treatment equipment manufacturing;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;

Shanghai Sidi Medical Laboratory Co., Ltd., established on 2015-10-26, Business scope includes for-profit medical institutions,Research on biological reagents for non-clinical diagnosis,Medical device management,Application software development,Sales,Sales of computers and auxiliary equipment,engaged in computer technology,medical technology,Technology development in the field of biotechnology,technology transfer,Technical Services,technical consulting,Biotechnology Extension Services,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]